Breast care pathway
Breast Ultrasound
From screening to diagnosis to staging to monitoring, GE Healthcare offers solutions across the entire breast care pathway including Invenia ABUS 2.0, designed to detect cancer in dense breast tissue.
Invenia ABUS 2.0 for dense breasts
Designed for screening
Improve breast cancer detection by 35.7 percent over mammography alone.2
Remarkable image quality
Look differently at dense breast tissue with advanced interpretation tools
AI Assistant
Helps to detect and characterize breast lesions for clinical confidence
LOGIQ E10 Series Ultrasound
AI decision support
Breast Assistant powered by Koios DS™ harnesses AI for clinical confidence
Advanced breast tools
Label, measure and describe lesions, nodules, and lymph nodes
Compare assistant
Compare a prior ultrasound, mammography, CT or MR image with current images
2D shear wave elastography
Quantiative measure of tissue elasticity shown in color-coded elastograms
LOGIQ Fortis™ Ultrasound
AI decision support
Breast Assistant powered by Koios DS™ harnesses AI for clinical confidence
Auto lesion segmentation
Saves keystrokes and provides consistency when measuring lesions
Measure assistant
Simple steps to assist the user with breast measurements
Breast productivity
Measurement package to make labeling, measuring and describing lesions easy
REFERENCES
- 1. Mandelson et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000; 92:1081–1087.
- 2. FDA PMA P110006 summary of safety and effectiveness